Kerecis

47 articles about Kerecis

• New Kerecis Medical-Fish-Skin Product Gets Quick Approval from Medicare Administrative Contractors

  8/25/2023

  Kerecis® Shield™, the new fish-skin wound-treatment product family for private doctors’ clinics, has been approved by multiple leading Medicare Administrative Contractors.

• Kerecis to Donate FDA-Approved Fish Skin for Burn Victims of Maui Wildfires

  8/14/2023

  Kerecis®, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, is donating its GraftGuide® fish-skin burn product for victims of the fires on Maui, Hawaii.

• Kerecis Combines Fish-Skin Graft and Silicone Cover for Wound Treatment

  4/27/2023

  SAWC – Kerecis® announced MariGen® Shield, which integrates the company’s proven fish-skin graft with a silicone contact layer for treating chronic and complex wounds.

• More Than 150 Million Americans Now Have Insurance Coverage for Kerecis’ Medical-Fish-Skin Wound Treatment

  4/18/2023

  Kerecis announced that, over the past year, 63 million more Americans became eligible for insurance coverage for the company’s fish-skin treatments, an increase of more than 70%.

• Kerecis Announces New Fish-Skin Burn Products

  1/20/2023

  Kerecis, the company pioneering the use of fish skin and fatty acids for tissue regeneration and protection, announced the release of two new products for the burn market, GraftGuide Mano™ and GraftGuide Micro™.

• Kerecis Announces First-Ever Fish-Skin Implantable Medical Product for Surgery

  10/19/2021

  Kerecis®, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection, has received authorization from the FDA to market Kerecis Omega3 SurgiBind™.

• Fish Skin Company Kerecis Announces Kerecis Omega3 MicroGraft

  6/3/2021

  The easy-to-use fish-skin graft fills a void as wound-treatment companies withdraw human-derived products per FDA guidance

• Kerecis Introduces Omega3 GraftGuide Fish Skin to Help Burn Victims Heal

  4/21/2021

  Kerecis®, the company that is pioneering the use of fish skin in tissue regeneration and wound care, announced its new product, Kerecis Omega3 GraftGuide™, at the 43rd Annual John A. Boswick Burn & Wound Care Symposium.

• U.S. Army Institute of Surgical Research Demonstrates Superior Results of Kerecis Omega3 Burn

  3/12/2021

  Researchers from the U.S. Army Institute of Surgical Research have found that Kerecis Omega3 Burn fish skin has better wound-healing properties than fetal bovine dermis.

• Medical-Fish-Skin Company Kerecis Names Mike Cadigan CFO

  1/21/2021

  Kerecis, the fastest growing company in the regenerative-tissue market in the United States, has appointed Mike Cadigan as its chief financial officer.

• Medical Fish Skin Company Kerecis Again Named Iceland’s Fastest Growing Company

  8/28/2020

  Company that uses fish skin to heal human wounds and damaged tissue continues its rapid growth

• Medical Fish Skin Company Kerecis Secures USD 21 Million Financing

  8/27/2020

  A Silicon Valley Bank credit facility and additional financing from other lenders increase operational flexibility and support the company’s long-term strategy

• Medical Fish Skin Company Kerecis to Release a Telemedicine App, Providing Access to Personalized Wound-Treatment Product Advice

  4/15/2020

  The new Kerecis telemedicine service, TeleKer™, enables healthcare providers to get timely, personalized advice on how to treat wounds with Kerecis products.

• Medical Fish Skin Company Kerecis Presents New Research at the Symposium on Advanced Wound Care

  10/11/2019

  Kerecis®, the company that is pioneering the use of fish skin in tissue regeneration and wound care, will present the results of multiple studies of its technology at the Symposium on Advanced Wound Care (SAWC) Fall meeting to be held in Las Vegas, Nevada, October 12 to 14 (booth 527).

• Former President of Iceland Joins the Board of Kerecis, the Medical Fish Skin Company

  8/5/2019

  Olafur Ragnar Grimsson, who was the President of Iceland for 20 years, has joined the board of Kerecis Limited.

• Medical Fish Skin Company Kerecis Limited Completes $16 Million Series C Offering

  6/13/2019

  Kerecis Limited, the company pioneering the use of fish skin in tissue regeneration, has completed a $16 million Series C funding round.

• Kerecis Named One of Iceland's Fastest Growing Companies for Three Years in a Row

  5/29/2019

  The Icelandic Growth Consortium has named Kerecis one of the country's fastest growing companies for three consecutive years.

• New Research on the Kerecis Fish-Skin-Grafts Wound Treatment to be Presented at the Symposium on Advanced Wound Care

  5/7/2019

  Dr. David Armstrong and Dr. Allen Raphael (DPM) will present results of multiple studies of Kerecis' medical fish skin at the Symposium on Advanced Wound Care (SAWC) Spring meeting, May 7 to 11, in San Antonio.

• President of Iceland Honors Clinicians for Medical Fish Skin Research

  3/8/2019

  Kerecis, the company pioneering the use of fish skin in tissue regeneration, announced that the President of Iceland, HE Gudni Johannesson, has awarded the company's Aurora Award to nurse Lisa Anne Jeffers and Dr. Bryan Folkers.

• Kerecis to Acquire Swiss Life-Science Company Phytoceuticals, Gains Approval of Kerecis Omega3 Wound for Reimbursement in Switzerland

  2/7/2019

  Kerecis, the company pioneering the use of fish skin in tissue regeneration, today received a notice from Swiss healthcare authorities that the company's lead product, Kerecis Omega3 Wound, will be reimbursed in Switzerland.